Literature DB >> 23595828

Development of mice with brain-specific deletion of floxed glud1 (glutamate dehydrogenase 1) using cre recombinase driven by the nestin promoter.

Melis Karaca1, Pierre Maechler.   

Abstract

In the brain, Glud1-encoded glutamate dehydrogenase plays a major role in the recycling of the neurotransmitter glutamate. We recently reported a new model of brain-specific Glud1 null mice (Cns-Glud1 (-/-)) lacking glutamate dehydrogenase in the central nervous system. Cns-Glud1 (-/-) mice exhibit reduced astrocytic glutamate breakdown and redirection of glutamate pathways without altering synaptic transmission. Cns-Glud1 (-/-) mice were generated using LoxP and Nestin-Cre technology. Nestin-Cre mice are widely used to investigate gene deletion in the central nervous system. However, the Nes-Cre transgene itself was reported to induce a phenotype related to body weight gain. Here, we review the potential side-effects of Nes-Cre and analysed Cns-Glud1 (-/-) body weight gain. Overall, Nestin-Cre mice may exhibit transient and moderate growth retardation during the few weeks immediately following weaning. Pending appropriate controls and homogenization of the genetic background, Nestin-Cre technology is a valuable tool enabling disruption of genes of interest in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23595828     DOI: 10.1007/s11064-013-1041-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

Review 1.  Astrocyte glutamate transport: review of properties, regulation, and physiological functions.

Authors:  C M Anderson; R A Swanson
Journal:  Glia       Date:  2000-10       Impact factor: 7.452

2.  Cre activity causes widespread apoptosis and lethal anemia during embryonic development.

Authors:  L A Naiche; Virginia E Papaioannou
Journal:  Genesis       Date:  2007-12       Impact factor: 2.487

3.  Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.

Authors:  C Postic; M Shiota; K D Niswender; T L Jetton; Y Chen; J M Moates; K D Shelton; J Lindner; A D Cherrington; M A Magnuson
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

4.  The human glutamate dehydrogenase gene family: gene organization and structural characterization.

Authors:  T M Michaelidis; G Tzimagiorgis; N K Moschonas; J Papamatheakis
Journal:  Genomics       Date:  1993-04       Impact factor: 5.736

5.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.

Authors:  F Tronche; C Kellendonk; O Kretz; P Gass; K Anlag; P C Orban; R Bock; R Klein; G Schütz
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

6.  Human GLUD2 glutamate dehydrogenase is expressed in neural and testicular supporting cells.

Authors:  Cleanthe Spanaki; Ioannis Zaganas; Kleopas A Kleopa; Andreas Plaitakis
Journal:  J Biol Chem       Date:  2010-03-01       Impact factor: 5.157

7.  Molecular basis of human glutamate dehydrogenase regulation under changing energy demands.

Authors:  Vasileios Mastorodemos; Ioannis Zaganas; Cleanthe Spanaki; Maria Bessa; Andreas Plaitakis
Journal:  J Neurosci Res       Date:  2005 Jan 1-15       Impact factor: 4.164

8.  Novel human glutamate dehydrogenase expressed in neural and testicular tissues and encoded by an X-linked intronless gene.

Authors:  P Shashidharan; T M Michaelidis; N K Robakis; A Kresovali; J Papamatheakis; A Plaitakis
Journal:  J Biol Chem       Date:  1994-06-17       Impact factor: 5.157

9.  Nestin-Cre mice are affected by hypopituitarism, which is not due to significant activity of the transgene in the pituitary gland.

Authors:  Christophe Galichet; Robin Lovell-Badge; Karine Rizzoti
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

10.  Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.

Authors:  Atsuko Yoshioka Higashi; Tomokatsu Ikawa; Masamichi Muramatsu; Aris N Economides; Akira Niwa; Tomohiko Okuda; Andrew J Murphy; Jose Rojas; Toshio Heike; Tatsutoshi Nakahata; Hiroshi Kawamoto; Toru Kita; Motoko Yanagita
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

View more
  6 in total

Review 1.  Deciphering direct and indirect influence of thyroid hormone with mouse genetics.

Authors:  Frédéric Picou; Teddy Fauquier; Fabrice Chatonnet; Sabine Richard; Frédéric Flamant
Journal:  Mol Endocrinol       Date:  2014-03-10

2.  The Amplifying Pathway of the β-Cell Contributes to Diet-induced Obesity.

Authors:  Laurène Vetterli; Stefania Carobbio; Francesca Frigerio; Melis Karaca; Pierre Maechler
Journal:  J Biol Chem       Date:  2016-05-02       Impact factor: 5.157

3.  Glutamate dehydrogenase is essential to sustain neuronal oxidative energy metabolism during stimulation.

Authors:  Michaela C Hohnholt; Vibe H Andersen; Jens V Andersen; Sofie K Christensen; Melis Karaca; Pierre Maechler; Helle S Waagepetersen
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-16       Impact factor: 6.200

Review 4.  Visual reporters for study of the osteoblast lineage.

Authors:  Emilie Roeder; Brya G Matthews; Ivo Kalajzic
Journal:  Bone       Date:  2016-09-08       Impact factor: 4.398

5.  Glutamate Dehydrogenase-Deficient Mice Display Schizophrenia-Like Behavioral Abnormalities and CA1-Specific Hippocampal Dysfunction.

Authors:  Sharon S Lander; Usman Khan; Nicole Lewandowski; Darpan Chakraborty; Frank A Provenzano; Susana Mingote; Sergiy Chornyy; Francesca Frigerio; Pierre Maechler; Hanoch Kaphzan; Scott A Small; Stephen Rayport; Inna Gaisler-Salomon
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

6.  Glutamate Dehydrogenase Is Important for Ammonia Fixation and Amino Acid Homeostasis in Brain During Hyperammonemia.

Authors:  Caroline M Voss; Lene Arildsen; Jakob D Nissen; Helle S Waagepetersen; Arne Schousboe; Pierre Maechler; Peter Ott; Hendrik Vilstrup; Anne B Walls
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.